Differences in metastatic patterns in relation to time between primary surgery and first relapse from breast cancer suggest synchronized growth of dormant micrometastases

Clinical Impact of Delaying Initiation of Adjuvant Chemotherapy in Patients With Breast Cancer

(2014) Debora de Melo Gagliato et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study

(2013) S Walters et al.   BRITISH JOURNAL OF CANCER

Surgery, wound healing, and metastasis: Recent insights and clinical implications

(2013) Wim Ceelen et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Factors Predicting Late Recurrence for Estrogen Receptor–Positive Breast Cancer

(2013) Ivana Sestak et al.   JNCI-Journal of the National Cancer Institute

What Can Be Learnt about Disease Progression in Breast Cancer Dormancy from Relapse Data?

(2013) Lisa Willis et al.   PLoS One

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

(2012) Christina Davies et al.   LANCET

Surgery of primary tumors in stage IV breast cancer: an updated meta-analysis of published studies with meta-regression

(2012) Fausto Petrelli et al.   MEDICAL ONCOLOGY

Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer

(2012) O. Straume et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Surgery of the primary tumor does not improve survival in stage IV breast cancer

(2011) Laura Dominici et al.   BREAST CANCER RESEARCH AND TREATMENT

Biologic markers determine both the risk and the timing of recurrence in breast cancer

(2011) Laura J. Esserman et al.   BREAST CANCER RESEARCH AND TREATMENT

Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis

(2011) Armando E. Giuliano   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Controversies in clinical cancer dormancy

(2011) J. W. Uhr et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Recurrence and mortality according to Estrogen Receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast

(2010) Romano Demicheli et al.   BMC CANCER

Breast Cancer Subtypes and the Risk of Local and Regional Relapse

(2010) K. David Voduc et al.   JOURNAL OF CLINICAL ONCOLOGY

Metastatic Behavior of Breast Cancer Subtypes

(2010) Hagen Kennecke et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

(2010) Jack Cuzick et al.   LANCET ONCOLOGY

Recurrence and mortality dynamics for breast cancer patients undergoing mastectomy according to estrogen receptor status: Different mortality but similar recurrence

(2009) Romano Demicheli et al.   CANCER SCIENCE

Tumor-vascular interactions and tumor dormancy 

(2008) GEORGE N. NAUMOV et al.   APMIS

New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target? 

(2008) PAUL GOSS et al.   APMIS

Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer 

(2008) M. W. RETSKY et al.   APMIS

Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy

(2008) A. M. Brewster et al.   JNCI-Journal of the National Cancer Institute